Awakn Announces Opening of Four Additional AWKN-001 Phase 3 Trial Sites

newsfileOct 22 07:30 ET

Awakn Selects Eurofins Discovery for Pharmacology Testing in New Chemical Entity (NCE) Pre-Clinical Program

newsfileOct 4 07:30 ET

Awakn Announces Key Progress in Its Aminoindane Pre-Clinical Program

newsfileAug 28 07:30 ET

Awakn Life Sciences Provides Update on Aminoindane New Chemical Entity Patent Portfolio

newsfileJul 22 17:00 ET

CSE Bulletin: Reinstatement - Awakn Life Sciences Corp. (AWKN)

newsfileMay 31 11:14 ET

Awakn Life Sciences Corp: MDA EN

SEDARMay 28 21:06 ET · Announcements